causes,c13.2,diagnosis,c13.6,follow-up,c13.16,questions to ask,c13.18,risk factors,c13.3,screening,c13.4,spread,c13.2,staging,c13.9,symptoms,c13.5,treatment,c13.10,types,c13.1,causes,c08.2,diagnosis,c08.6,diagram,c08.5,follow-up,c08.15,investigational drugs,p35.7,questions to ask,c08.17,recurrence ,c08.16,risk factors,c08.3,screening,c08.4,spread,c08.2;c08.5,staging,c08.7,symptoms,c08.5,treatment,c08.8,types,c08.2;c08.10,unknown primary site,c07.1,defined,p36.1,function,p01.1,oncogenes,p01.5,suppressor,p01.5,therapy,p36.11,tumor-causing,p36.3,tumor-suppressing,p36.3,childhood cancers,c10a.3,esophageal cancer,c12.3,Kaposi's sarcoma,c16.4,melanoma,c25.5,mesothelioma,c26.3,ovarian cancer,c29.4,risk factor,p34.5,skin cancer,c37.5,child,c10b.2;c10b.17,ovarian,13,unknown primary site,c07.1;c07.3,brain stem,c05.18;c10b.2;c10b.13,child,c10a.2;c10b.1;c10b.13;c10b.20,
causes,c30.2,diagnosis,c30.6,follow-up,c30.15,mixed,c30.1,questions to ask,c30.17,recurrence,c30.16,risk factors,c30.3,screening,c30.4,spread,c30.2,staging,c30.7,symptoms,c30.5,treatment,c30.10,types,c30.1,